Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 liquidated — weigh against the wins.
1 vehicle on file, newest listing first
Rhonda R. Mims are our Director Nominees. Kenneth A. Burdick, who has agreed to serve as chairman of our board of directors, has approximately 30 years of healthcare executive and operations experience, including prior roles as a public -company chief executive officer and Board member, and has a demonstrated track record of growing healthcare companies. Most recently, Mr. Burdick served as Executive Vice President, Markets and Products at Centene from February 2020 through January 2021, where he held national P&L responsibility for approximately $90 billion in annual revenue. Mr. Burdick joined Centene as part of the executive leadership team, following Centene’s $19 billion acquisition of WellCare in January 2020. From January 2015 to January 2020, Mr. Burdick served as CEO of WellCare and led the company in its mission to provide quality, cost -effective healthcare solutions for the company’s members, providers and government customers. Mr.
This record is keyed to SEC CIK 0001682144 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 46 institutional-holder rows on these vehicles, under 20 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.